Literature DB >> 2584383

Molecular techniques for the detection of Chlamydia trachomatis.

E M Peterson1, R Oda, R Alexander, J R Greenwood, L M de la Maza.   

Abstract

A DNA probe assay (PACE; Gen-Probe, San Diego, Calif.) was compared with a culture reference method for the detection of Chlamydia trachomatis. Using stock isolates of each of the 15 serovars (A to K, Ba, L1, L2, and L3) of C. trachomatis, the lower limit of sensitivity for the DNA probe ranged between 1,086 inclusion-forming units (IFU) for serovar E (Bour) to 2,930 IFU for serovar L1 (440), with the only exception being serovar C (TW-3), with which 99 IFU was detected. There was no cross-reactivity with Chlamydia psittaci (Texas turkey) and Chlamydia pneumoniae (TWAR-183). Bacterial and fungal isolates representing 14 species of normal vaginal flora as well as Neisseria gonorrhoeae gave negative results with the DNA probe when tested at a level of 1.5 X 10(7) CFU/ml. In addition, the DNA probe, a direct fluorescent-antibody stain (DFA) (MicroTrak; Syva Corp., Palo Alto, Calif.), and an enzyme-linked immunosorbent assay (Chlamydiazyme; Abbott Laboratories, North Chicago, Ill.) were compared with culture for the detection of C. trachomatis, using 196 clinical cervical samples. Of the 196 samples, 20 (10%) were culture positive. Of the 176 culture-negative samples, 1 was not evaluated by DNA probe and 4, because of a lack of cellular material, were not evaluated by DFA. The sensitivities of the DNA probe, DFA, and enzyme-linked immunosorbent assay were 60, 75, and 85%, respectively, and specificities were 95, 99, and 97%, respectively. Of the false-positive direct results, there was only one specimen with which more than one direct method was positive, and with this specimen all three direct methods were positive. The majority of false-negative results by the direct methods were from specimens which by the culture method gave <100 IFU per culture.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584383      PMCID: PMC267023          DOI: 10.1128/jcm.27.10.2359-2363.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Use of nucleic acid probes for the detection of sexually transmitted infectious agents.

Authors:  J E Horn; T Quinn; M Hammer; L Palmer; S Falkow
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

2.  Comparison of monoclonal antibody staining and culture in diagnosing cervical chlamydial infection.

Authors:  E S Lipkin; J V Moncada; M A Shafer; T E Wilson; J Schachter
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens.

Authors:  J B Mahony; M A Chernesky
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

4.  Problems of spectrum and bias in evaluating the efficacy of diagnostic tests.

Authors:  D F Ransohoff; A R Feinstein
Journal:  N Engl J Med       Date:  1978-10-26       Impact factor: 91.245

5.  Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease?

Authors:  J Schachter; J Moncada; C R Dawson; J Sheppard; P Courtright; M E Said; S Zaki; S F Hafez; A Lorincz
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

6.  Detection of Chlamydia trachomatis using consecutive endocervical swabs. Prevalence in asymptomatic female adolescents and women attending a sexually transmitted disease clinic.

Authors:  T J Hernandez; K L Noller; T F Smith
Journal:  J Reprod Med       Date:  1986-06       Impact factor: 0.142

7.  Detection of Chlamydia trachomatis antigens by enzyme immunoassay and immunofluorescence in genital specimens from symptomatic and asymptomatic men and women.

Authors:  M A Chernesky; J B Mahony; S Castriciano; M Mores; I O Stewart; S J Landis; W Seidelman; E J Sargeant; C Leman
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

8.  Chlamydia trachomatis: its role in tubal infertility.

Authors:  R C Brunham; I W Maclean; B Binns; R W Peeling
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

9.  Detection of Chlamydia trachomatis in clinical specimens by nucleic acid spot hybridization.

Authors:  T Hyypiä; A Jalava; S H Larsen; P Terho; V Hukkanen
Journal:  J Gen Microbiol       Date:  1985-04

10.  Immunodiagnosis of sexually transmitted disease.

Authors:  J Schachter
Journal:  Yale J Biol Med       Date:  1985 Sep-Oct
View more
  18 in total

Review 1.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

2.  Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction.

Authors:  H C Claas; W J Melchers; I H de Bruijn; M de Graaf; W C van Dijk; J Lindeman; W G Quint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  Detection of Chlamydia trachomatis by the polymerase chain reaction in swabs and urine from men with non-gonococcal urethritis.

Authors:  H M Palmer; C B Gilroy; B J Thomas; P E Hay; C Gilchrist; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

4.  Direct identification of bacterial isolates in blood cultures by using a DNA probe.

Authors:  T E Davis; D D Fuller
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

5.  Evaluation of the rapid CLEARVIEW Chlamydia test for direct detection of chlamydiae from cervical specimens.

Authors:  N J Stratton; L Hirsch; F Harris; L M de la Maza; E M Peterson
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

6.  Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens.

Authors:  C A Gaydos; C A Reichart; J M Long; L E Welsh; T M Neumann; E W Hook; T C Quinn
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

7.  Sensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid.

Authors:  J G Kuipers; K Scharmann; J Wollenhaupt; E Nettelnbreker; S Hopf; H Zeidler
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

8.  Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  J A Kluytmans; H G Niesters; J W Mouton; W G Quint; J A Ijpelaar; J H Van Rijsoort-Vos; L Habbema; E Stolz; M F Michel; J H Wagenvoort
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Comparison of the Clearview Chlamydia, the PACE 2 assay, and culture for detection of Chlamydia trachomatis from cervical specimens in a low-prevalence population.

Authors:  J Blanding; L Hirsch; N Stranton; T Wright; S Aarnaes; L de la Maza; E M Peterson
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

10.  Comparative evaluation of detection assays for Chlamydia trachomatis.

Authors:  R Warren; B Dwyer; M Plackett; K Pettit; N Rizvi; A M Baker
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.